You are viewing: US Structural Heart Devices Market analysis

The US Structural Heart Devices Market was valued at $2528.3 Million in 2024 and projected to reach to $4243.3 Million by 2029, representing a compound annual growth rate of 10.9%. The US Structural Heart Devices Market is positioned for sustained growth through 2029, driven by technological innovations in transcatheter devices and supportive reimbursement frameworks.

US Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Structural Heart Devices Market Trends and Insights

  • The US market is driven by an aging population, rising prevalence of structural heart conditions, and increasing adoption of minimally invasive procedures.
  • In the US, technological advancements in transcatheter devices and growing reimbursement support are accelerating market penetration across healthcare systems. The US structural heart devices sector benefits from strong regulatory frameworks, established clinical evidence, and high healthcare spending.
  • Between 2024 and 2029, the US is expected to maintain a 10.9% compound annual growth rate, outpacing global trends.
  • The US market's expansion is supported by favorable demographics, improved patient outcomes, and expanding procedural volumes in both hospital and outpatient settings..

Key Market Statistics

  • CAGR (2024-2029) 10.9% CAGR
  • Market Size, 2024 ~USD 2528.3 Million
  • Forecast, 2029 ~USD 4243.3 Million
  • Country US

US Structural Heart Devices Market Overview

Market Valuation Growth :

The US Structural Heart Devices Market is valued at $2,528.3 million in 2024, with a strong projected CAGR of 10.9%, reaching $4,243.3 million by 2029, significantly outpacing the global growth rate of 9.5%.

Aging Population Driver :

The US demographic shift toward an aging population is a primary catalyst for market expansion, as structural heart conditions become increasingly prevalent among seniors, driving demand for innovative treatment solutions.

Minimally Invasive Adoption :

Growing preference for transcatheter and minimally invasive procedures in the US healthcare system is accelerating device adoption, reducing patient recovery times and hospital stays while improving clinical outcomes.

Reimbursement Landscape :

Expanding insurance coverage and favorable reimbursement policies from Medicare and private payers are removing financial barriers to adoption, enabling broader patient access to advanced structural heart interventions across US healthcare systems.

US Structural Heart Devices Market Dynamics

  • The aging US population combined with rising prevalence of conditions like atrial fibrillation, mitral regurgitation, and aortic stenosis creates substantial demand for minimally invasive solutions.
  • Healthcare providers are increasingly adopting these advanced devices due to improved patient outcomes and reduced procedural complications.
  • Market expansion will be further supported by ongoing clinical evidence generation and FDA approvals of next-generation devices.
  • The competitive landscape continues to intensify as major medical device manufacturers invest heavily in R&D to capture market share in this high-growth segment..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US Structural Heart Devices Market is valued at $2,528.3 million in 2024 and will grow to $4,243.3 million by 2029 at a 10.9% CAGR.
    • The US market benefits from advanced healthcare infrastructure, strong reimbursement policies, and high adoption rates of minimally invasive cardiac procedures.
    • Aging demographics and increasing prevalence of structural heart disease are primary growth drivers in the US market.
    • The US represents a mature, high-value market with significant innovation in transcatheter and device-based interventions.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    US Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    US: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS459.7503.4549.5600.4656717.7786861.49.4
    HOSPITALS30763390.537254096.14504.94960.55467.16030.610.1
    OTHERS END USERS441.7491.4545604.9671.4746.3830.2924.311.1
    TOTAL3977.44385.34819.65301.35832.46424.47083.37816.310.2

    Target Audience

    • Medical Device Manufacturers : Device companies need US-specific market data to develop go-to-market strategies, allocate R&D resources, and identify gaps in the structural heart portfolio to capture share in this rapidly expanding $4.2B market by 2029.
    • Healthcare Investors & PE Firms : Investment professionals require validated US market sizing, growth projections, and competitive dynamics to evaluate acquisition targets, fund healthcare startups, and make informed capital deployment decisions in the structural heart space.
    • Hospital Systems & Healthcare Providers : Hospital administrators and interventional cardiologists need market intelligence on device innovations, reimbursement trends, and clinical outcomes to optimize procurement strategies and improve patient care delivery in structural heart interventions.
    • Regulatory & Compliance Professionals : Regulatory affairs teams require US-specific FDA approval pathways, reimbursement policies, and market access strategies to navigate the complex regulatory environment and accelerate product launches in the structural heart market.
    • Market Research & Strategy Consultants : Consulting firms and research organizations need comprehensive US market data to support client advisory work, competitive analysis, and strategic recommendations for stakeholders across the structural heart devices ecosystem.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise US market valuation ($2,528.3M in 2024) and verified 10.9% CAGR projections through 2029 to support strategic planning, investment decisions, and competitive positioning in the high-growth structural heart segment.
    • US-Specific Regulatory & Reimbursement Insights : Access detailed analysis of FDA approval pathways, Medicare/private payer reimbursement trends, and coverage policies unique to the US market to navigate regulatory requirements and optimize market entry strategies.
    • Demographic & Clinical Opportunity Assessment : Understand the US aging population dynamics, prevalence of structural heart conditions, and adoption rates of minimally invasive procedures to identify high-potential patient segments and geographic markets for targeted expansion.
    • Competitive Landscape & Technology Trends : Benchmark against competitors and stay informed on transcatheter device innovations, emerging technologies, and clinical evidence generation specific to the US market to maintain competitive advantage and accelerate product development.
    • Revenue Forecasting & Investment Planning : Leverage detailed US market projections and segment-level forecasts to build accurate financial models, justify capital allocation, and identify partnership or acquisition opportunities in the structural heart devices sector.

    Frequently asked questions

    What is the current size of the US Structural Heart Devices Market?

    The US Structural Heart Devices Market was valued at $2,528.3 million in 2024 and is expected to reach $4,243.3 million by 2029.

    What is the projected growth rate for the US market?

    The US Structural Heart Devices Market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.

    What factors are driving growth in the US market?

    Key drivers in the US include an aging population, rising prevalence of structural heart conditions, technological advancements in transcatheter devices, and favorable reimbursement policies.

    How does the US market compare to global trends?

    The US market's 10.9% CAGR outpaces the global market growth rate of 9.5%, reflecting strong healthcare infrastructure and high procedural adoption in the US.

    What types of devices are included in the US market?

    The US market encompasses transcatheter aortic valve replacement (TAVR), mitral valve repair devices, left atrial appendage (LAA) closure devices, and other structural heart intervention platforms.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status